Trent Capital Management’s Gilead Sciences GILD Stock Holding History

Trent Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$11K	Buy	+155	New	+$11.5K	0.01%	71

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Trent Capital Management's GILD Position: Q4 2016 in Review

Trent Capital Management opened a new position in Gilead Sciences (GILD) in Q4 2016: 155 shares worth $11K. The stake represents 0.01% of the portfolio and ranks #71 among its holdings.

1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Trent Capital Management held 155 shares of Gilead Sciences worth $11K as of Q4 2016.
Gilead Sciences was a new Trent Capital Management position in Q4 2016.
Gilead Sciences made up 0.01% of Trent Capital Management's portfolio in Q4 2016, its #71 holding.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Trent Capital Management's 13F filing for Q4 2016, filed 1 Feb 2017.